Aqr Capital Management LLC Dr Reddys Laboratories LTD Transaction History

Aqr Capital Management LLC

$64.6 Billion
Q2 2024

A detailed history of Aqr Capital Management LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Aqr Capital Management LLC holds 91,186 shares of RDY stock, worth $7.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

91,186

Previous 98,784 7.69%

Holding current value

$7.24 Million

Previous $7.25 Million 4.11%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$68.26 - $76.19 $518,639 - $578,891	-7,598 Reduced 7.69%	91,186 $6.95 Million
Q1 2024 May 15, 2024	BUY	$67.36 - $77.59 $928,557 - $1.07 Million	13,785 Added 16.22%	98,784 $7.25 Million
Q4 2023 Feb 14, 2024	SELL	$64.27 - $69.9 $869,187 - $945,327	-13,524 Reduced 13.73%	84,999 $5.91 Million
Q3 2023 Nov 14, 2023	BUY	$61.9 - $72.77 $192,632 - $226,460	3,112 Added 3.26%	98,523 $6.59 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $1.19 Million - $1.41 Million	22,310 Added 30.52%	95,411 $6.02 Million
Q1 2023 May 15, 2023	SELL	$51.63 - $56.93 $1.75 Million - $1.93 Million	-33,873 Reduced 31.66%	73,101 $4.16 Million
Q4 2022 Feb 14, 2023	SELL	$51.15 - $57.45 $417,332 - $468,734	-8,159 Reduced 7.09%	106,974 $5.54 Million
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $219,310 - $251,921	-4,395 Reduced 3.68%	115,133 $6.03 Million
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $920,252 - $1.08 Million	-18,546 Reduced 13.43%	119,528 $6.62 Million
Q1 2022 May 16, 2022	SELL	$48.27 - $65.25 $873,107 - $1.18 Million	-18,088 Reduced 11.58%	138,074 $7.7 Million
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $2.61 Million - $2.95 Million	-43,832 Reduced 21.92%	156,162 $10.2 Million
Q3 2021 Nov 15, 2021	BUY	$60.19 - $75.29 $1.21 Million - $1.51 Million	20,080 Added 11.16%	199,994 $13 Million
Q2 2021 Aug 16, 2021	SELL	$62.12 - $74.2 $625,921 - $747,639	-10,076 Reduced 5.3%	179,914 $13.2 Million
Q1 2021 May 17, 2021	BUY	$57.98 - $73.08 $980,905 - $1.24 Million	16,918 Added 9.78%	189,990 $11.7 Million
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $685,579 - $780,625	-10,950 Reduced 5.95%	173,072 $12.3 Million
Q3 2020 Nov 16, 2020	SELL	$51.39 - $72.41 $674,493 - $950,381	-13,125 Reduced 6.66%	184,022 $12.8 Million
Q2 2020 Aug 17, 2020	SELL	$39.55 - $54.65 $3.18 Million - $4.39 Million	-80,373 Reduced 28.96%	197,147 $10.5 Million
Q1 2020 May 15, 2020	SELL	$34.75 - $45.85 $1.76 Million - $2.33 Million	-50,776 Reduced 15.47%	277,520 $11.2 Million
Q4 2019 Feb 14, 2020	BUY	$36.66 - $41.78 $435,154 - $495,928	11,870 Added 3.75%	328,296 $13.3 Million
Q3 2019 Nov 14, 2019	SELL	$34.82 - $39.26 $1.84 Million - $2.08 Million	-52,964 Reduced 14.34%	316,426 $12 Million
Q2 2019 Aug 14, 2019	SELL	$36.05 - $42.76 $4.83 Million - $5.72 Million	-133,886 Reduced 26.6%	369,390 $13.8 Million
Q1 2019 May 14, 2019	SELL	$35.77 - $40.57 $1.52 Million - $1.72 Million	-42,458 Reduced 7.78%	503,276 $20.4 Million
Q4 2018 Feb 14, 2019	BUY	$31.89 - $38.44 $424,838 - $512,097	13,322 Added 2.5%	545,734 $20.6 Million
Q3 2018 Nov 15, 2018	SELL	$29.25 - $36.73 $17,403 - $21,854	-595 Reduced 0.11%	532,412 $18.4 Million
Q2 2018 Aug 14, 2018	SELL	$28.49 - $35.06 $53,789 - $66,193	-1,888 Reduced 0.35%	533,007 $17.2 Million
Q1 2018 May 15, 2018	SELL	$31.93 - $39.54 $3.04 Million - $3.76 Million	-95,210 Reduced 15.11%	534,895 $17.5 Million
Q4 2017 Feb 14, 2018	SELL	$34.15 - $37.62 $8.96 Million - $9.88 Million	-262,513 Reduced 29.41%	630,105 $23.7 Million
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $26.9 Million - $33.7 Million	892,618	892,618 $31.8 Million

Others Institutions Holding RDY

# of Institutions

233

Shares Held

24M

Call Options Held

14.6K

Put Options Held

2.8K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13.2B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Dr Reddys Laboratories LTD Transaction History